ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

ドネペジル塩酸塩

Donepezil Hydrochloride

HCID 5741
反応を作成
印刷

データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます

基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
120011-70-3
標準SMILES
COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2.Cl
InChIKey
XWAIAVWHZJNZQQ-UHFFFAOYSA-N
分子式
C24H30ClNO3
平均分子量
416 g/mol
単同位体質量
415.1914215

概要

Donepezil Hydrochloride is the hydrochloride salt of a piperidine derivative with neurocognitive-enhancing activity. Donepezil reversibly inhibits acetylcholinesterase, thereby blocking the hydrolysis of the neurotransmitter acetylcholine and, consequently, increasing its activity. This agent may improve neurocognitive function in Alzheimer's disease, reduce sedation associated with opioid treatment of cancer pain, and improve neurocognitive function in patients who have received radiation therapy for primary brain tumors or brain metastases.

名称と識別子

優先名称
Donepezil Hydrochloride
IUPAC
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one;hydrochloride
現地名
ドネペジル塩酸塩
英語名
Donepezil Hydrochloride
分子式
C24H30ClNO3
分子量
415.95

名称と別名

Donepezil hydrochloride120011-70-3Donepezil HClBNAGAricept ODTE-2020ADLARITYE2020Aricept EvessDTXSID0046698NSC-737535NSC-758882
名称をさらに表示
ドネペジル塩酸塩2-(1-ベンジル-4-ピペリジルメチル)-5,6-ジメトキシ-1-インダノン塩酸塩ドネペジル 塩酸塩ドネペジル 塩酸塩 一水和物ドネペジル塩酸塩 (JP17)塩酸ドネペジル1-ベンジル-4-[[5,6-ジメトキシ-1-オキソインダン-2-イル]メチル]ピペリジン・塩酸2-(1-ベンジル-4-ピペリジニルメチル)-5,6-ジメトキシ-1-インダノン・塩酸塩アリセプト-Drac-(R*)-2,3-ジヒドロ-5,6-ジメトキシ-2-[(1-ベンジルピペリジン-4-イル)メチル]-1H-インデン-1-オン・塩酸塩アリセプト2-(1-ベンジル-4-ピペリジルメチル)-5,6-ジメトキシ-1-インダノン=塩酸塩1-ベンジル-4-{[(2RS)-5,6-ジメトキシ-1-オキソインダン-2-イル]メチル}ピペリジン-1-イウム=クロリド2,3-ジヒドロ-5,6-ジメトキシ-2-(1-ベンジル-4-ピペリジニル)メチル-1H-インデン-1-オン・塩酸ARICEPTDonepeziDonepezil-d7 HydrochlorideAKOS 226-31DOPEZIL HCLDonepezil HCI6-diMethoxy-2
3O2T2PJ89DDonepezil HyrochlorideDTXCID80266981-Benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine hclDonepezil Hyrochloride 5mgDonepezil Hydrochloride 10mgNAMZARIC COMPONENT DONEPEZIL HYDROCHLORIDERefChem:56499

物性

構造計算による物性補完中

極性表面積
38.8 Ų
水素結合供与体数
1
水素結合受容体数
4
回転可能結合数
6
重原子数
29
形式電荷
0
複雑度
510

実験および物理化学的性質

Human Drugs · 2 件

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Collision Cross Section196.6 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

物理化学的性質

融点
220 · 220-222°C
貯蔵温度
room temp
水溶解度
Soluble in water
溶解性
10.4 mg/mL · insoluble in EtOH; insoluble in DMSO; ≥10.4 mg/mL in H2O
外見
粉
色
ホワイトからオフホワイト
Merck
14 · 14,3419
安定性
Hygroscopic
InChI
InChI=1S/C24H29NO3.ClH/c1-27-22-14-19-13-20(24(26)21(19)15-23(22)28-2)12-17-8-10-25(11-9-17)16-18-6-4-3-5-7-18;/h3-7,14-15,17,20H,8-13,16H2,1-2H3;1H
InChIKey
XWAIAVWHZJNZQQ-UHFFFAOYSA-N
SMILES
C1(=O)C2=C(C=C(OC)C(OC)=C2)CC1CC1CCN(CC2=CC=CC=C2)CC1.[H]Cl
CAS データベース
120011 · 120011-70-3(CAS DataBase Reference)

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 4 件

Danger

H300 (17.9%): Fatal if swallowed [Danger Acute toxicity, oral]

P264, P264+P265, P270, P280, P301+P316, P305+P351+P338, P321, P330, P337+P317, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 84 reports by companies from 15 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Hazard Classes and CategoriesAcute Tox. 2 (17.9%)

毒性情報

Treatment · 1 件

If the compound has been ingested, rapid gastric lavage should be performed using 5% sodium bicarbonate. For skin contact, the skin should be washed with soap and water. If the compound has entered the eyes, they should be washed with large quantities of isotonic saline or water. In serious cases, atropine and/or pralidoxime should be administered. Anti-cholinergic drugs work to counteract the effects of excess acetylcholine and reactivate AChE. Atropine can be used as an antidote in conjunction with pralidoxime or other pyridinium oximes (such as trimedoxime or obidoxime), though the use of '-oximes' has been found to be of no benefit, or possibly harmful, in at least two meta-analyses. Atropine is a muscarinic antagonist, and thus blocks the action of acetylcholine peripherally.

Health Effects · 1 件

Acute exposure to cholinesterase inhibitors can cause a cholinergic crisis characterized by severe nausea/vomiting, salivation, sweating, bradycardia, hypotension, collapse, and convulsions. Increasing muscle weakness is a possibility and may result in death if respiratory muscles are involved. Accumulation of ACh at motor nerves causes overstimulation of nicotinic expression at the neuromuscular junction. When this occurs symptoms such as muscle weakness, fatigue, muscle cramps, fasciculation, and paralysis can be seen. When there is an accumulation of ACh at autonomic ganglia this causes overstimulation of nicotinic expression in the sympathetic system. Symptoms associated with this are hypertension, and hypoglycemia. Overstimulation of nicotinic acetylcholine receptors in the central nervous system, due to accumulation of ACh, results in anxiety, headache, convulsions, ataxia, depression of respiration and circulation, tremor, general weakness, and potentially coma. When there is expression of muscarinic overstimulation due to excess acetylcholine at muscarinic acetylcholine receptors symptoms of visual disturbances, tightness in chest, wheezing due to bronchoconstriction, increased bronchial secretions, increased salivation, lacrimation, sweating, peristalsis, and urination can occur. Certain reproductive effects in fertility, growth, and development for males and females have been linked specifically to organophosphate pesticide exposure. Most of the research on reproductive effects has been conducted on farmers working with pesticides and insecticdes in rural areas. In females menstrual cycle disturbances, longer pregnancies, spontaneous abortions, stillbirths, and some developmental effects in offspring have been linked to organophosphate pesticide exposure. Prenatal exposure has been linked to impaired fetal growth and development. Neurotoxic effects have also been linked to poisoning with OP pesticides causing four neurotoxic effects in humans: cholinergic syndrome, intermediate syndrome, organophosphate-induced delayed polyneuropathy (OPIDP), and chronic organophosphate-induced neuropsychiatric disorder (COPIND). These syndromes result after acute and chronic exposure to OP pesticides.

化学と産業

薬理情報

Metabolism/Metabolites · 1 件

Donepezil is metabolized by CYP 450 isoenzymes 2D6 and 3A4 in the liver and also undergoes glucuronidation. The main metabolite, 6-O-desmethyl donepezil, has been reported to inhibit AChE to the same extent as donepezil in vitro. Route of Elimination: Donepezil is both excreted in the urine intact and extensively metabolized to four major metabolites, two of which are known to be active, and a number of minor metabolites, not all of which have been identified. Half Life: 70 hours

FDA Pharmacological Classification · 2 件

DONEPEZIL HYDROCHLORIDE

Cholinesterase Inhibitors [MoA]; Cholinesterase Inhibitor [EPC]

MeSH Pharmacological Classification · 2 件

Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system.

Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms.

用途と製造

UsesFor the palliative treatment of mild to moderate dementia of the Alzheimer's type.
応用分野 · 4 件

用途アセチルコリンエステラーゼ 阻害剤です。アセチルコリンエステラーゼを 可逆的に阻害することにより脳内アセチルコ リン量を増加させ、脳内コリン作動性神経系 賦活作用を示します。

用途アセチルコリンエステラーゼ 阻害剤です。アセチルコリンエステラーゼを 可逆的に阻害することにより脳内アセチルコ リン量を増加させ、脳内コリン作動性神経系 賦活作用を示します。

関連反応

59 件
反応記録を作成
HRID 227556 の反応式
HRID 227556生成物として
HRID 227557 の反応式
HRID 227557生成物として
HRID 456985 の反応式
HRID 456985生成物として
HRID 480396 の反応式
HRID 480396反応物として
HRID 878393 の反応式
HRID 878393反応物として
HRID 967309 の反応式
HRID 967309反応物として
HRID 1454359 の反応式
HRID 1454359生成物として
HRID 1454360 の反応式
HRID 1454360生成物として
前へ1 / 8 ページ

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート

データベース識別子

CAS
120011-70-3
PubChem CID
5741
DTXSID
DTXSID0046698
ChEMBL
CHEMBL1678
UNII
3O2T2PJ89D
EC Number
620-543-2
化学的性質 · 1 件

化学的特性Donepezil hydrochloride (E2020) alongside with galantamine and rivastigmine is a piperidine-based drug developed specifically for Alzheimer’s disease (AD) by Eisai Pharmaceuticals (Aricept). Donepezil hydrochloride is commonly referred to in the pharmacological literature as E2020. It has an empirical formula of C24H29NO3HCl and a molecular weight of 415.96. Donepezil hydrochloride is a white crystalline powder and is freely soluble in chloroform, soluble in water and in glacial acetic acid, slightly soluble in ethanol and in acetonitrile, and practically insoluble in ethyl acetate and in n-hexane.

Exposure RoutesDonepezil is well absorbed with a relative oral bioavailability of 100% and reaches peak plasma concentrations in 3 to 4 hours.
Toxicity Summary · 1 件

Donepezil is a cholinesterase or acetylcholinesterase (AChE) inhibitor. A cholinesterase inhibitor (or 'anticholinesterase') suppresses the action of acetylcholinesterase. Because of its essential function, chemicals that interfere with the action of acetylcholinesterase are potent neurotoxins, causing excessive salivation and eye-watering in low doses, followed by muscle spasms and ultimately death. Nerve gases and many substances used in insecticides have been shown to act by binding a serine in the active site of acetylcholine esterase, inhibiting the enzyme completely. Acetylcholine esterase breaks down the neurotransmitter acetylcholine, which is released at nerve and muscle junctions, in order to allow the muscle or organ to relax. The result of acetylcholine esterase inhibition is that acetylcholine builds up and continues to act so that any nerve impulses are continually transmitted and muscle contractions do not stop. Among the most common acetylcholinesterase inhibitors are phosphorus-based compounds, which are designed to bind to the active site of the enzyme. The structural requirements are a phosphorus atom bearing two lipophilic groups, a leaving group (such as a halide or thiocyanate), and a terminal oxygen.

Signs and Symptoms · 1 件

Symptoms of overdose include severe nausea, vomiting, salivation, sweating, bradycardia, hypotension, respiratory depression, collapse and convulsions. Increasing muscle weakness is a possibility and may result in death if respiratory muscles are involved.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 6 件

Drug Induced Liver Injury Rank (DILIrank 2.0)

Donepezil hydrochloride

vLess-DILI-concern

3

Adverse reactions

DOI:10.1016/j.drudis.2016.02.015

安全データ

wgk
1
rtecs
NK8927885
ridadr
UN 2811
hs_code
2933.39.9200
risk_code
36/37/38
hazard_code
Xi
safety_code
26-36
hazard_class
6.1
packing_group
II
Hazard Classifications
Acute Tox. 2 OralEye Irrit. 2
ストレージクラス
6.1A - Combustible acute toxic Cat. 1 and 2very toxic hazardous materials

使用Donepezil hydrochloride is an inhibitor of acetylcholinesterase with a labelled nootropic. It has been used in dose-response experiment to study its efficacy in ameliorating nicotine withdrawal-induced deficits in contextual conditioning in mice. It has also been intraperitoneally injected into rats to study its ability to improve social behavioral deficits, repetitive behavior and hyperactivity. Labeled Donepezil, intended for use as an internal standard for the quantification of Donepezilby GC- or LC-mass spectrometry.

一般的な説明Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.Donepezil Hydrochloride is known as a selective, reversible inhibitor of acetylcholinesterase enzyme. It exhibits therapeutic effect by raising the acetylcholine concentrations and improving the cholinergic function. It can be used in the treatment of mild to moderate dementia of the Alzheimer′s type.

調製方法 · 1 件

製造方法Donepezil Hydrochloride is being synthesized from alkylidene or arylidene-2-indanone formed by Aldol condensation chemistry as key intermediates (Sugimoto and co-workers)) followed by catalytic reduction affording donepezil hydrochloride with an overall yield of 27%.Benzyl chloride (1.92 g, 0.0156 mol), potassium carbonate (2.28 g, 0.0165 mol) and PEG-200 (80 mg, 2% by weight) were added to a clear biphasic solution of 2-[(4-piperidyl)methyl]-5,6-dimethoxyindan-1-one 6 (4 g, 0.0138 mol) in 9 : 1 EtOAc–H2O (40 ml). The reaction mixture was heated to 50—55 °C and monitored on TLC. After completion of reaction (14 h), the solid was filtered and the filtrate was washed with water (4 ml). The EtOAc layer was separated, added water (8 ml) and acidified with conc. HCl till a pH 2. EtOAc layer was discarded and the acidic aqueous layer was extracted with CH2Cl2 (2*16 ml). The CH2Cl2 layer was separated, dried over anhydrous Na2SO4, filtered and evaporated under vacuum to yield the crude salt as a residue. The residue was dissolved in methanol (20 ml) followed by the addition of isopropyl ether (40 ml) and stirred for a further 1 h. The precipitated solid was filtered and dried under vacuum to yield pure donepezil hydrochloride.A New Commercially Viable Synthetic Route for Donepezil Hydrochloride

上流・下流製品情報

上流原料

ブチルリチウムジイソプロピルアミン水酸化パラジウム / 炭素

補足説明

定義ChEBI: Donepezil hydrochloride is a centrally acting reversible acetyl cholinesterase inhibitor. Its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine.